国际眼科纵览

• 综述 •    下一篇

择期眼科手术围术期抗栓管理

王宁 秦明照 周丹   

  1. 100730 首都医科大学附属北京同仁医院干部医疗科(王宁、秦明照);首都医科大学附属北京同仁医院眼科(周丹)
  • 收稿日期:2015-06-17 出版日期:2015-10-22 发布日期:2015-10-27
  • 通讯作者: 秦明照 E-mail:qinmingzhao58@163.com

Perioperative management of antithrombotic therapies in patients with elective ophthalmic surgery

WANG Ning1, QIN Ming-zhao1, ZHOU Dan2   

  1.  Department of Geriatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100730,China; 2 Department of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beij--ing 100730,China
  • Received:2015-06-17 Online:2015-10-22 Published:2015-10-27
  • Contact: QIN Ming\|zhao1 E-mail:qinmingzhao58@163.com

摘要:

眼科手术中的老年患者常合并全身性疾病,需应用多种药物,特别是抗栓药物。不同类型的眼科手术围术期应用抗栓药物的出血风险不同,因此需要调整抗栓策略,对抗血小板药物及抗凝药物进行管理,以平衡术中及术后出血及血栓的风险。(国际眼科纵览,2015, 39: 289-296)

Abstract:

Abstract】Elderly patients presenting for ophthalmic surgery are often having systemic diseases and using multiple drugs, particularly antithrombotic drugs. Different antithrombotic drugs has different perioperative bleeding risks in a variety of ophthalmic surgeries, thus it is necessary to adjust antithrombotic strategies, manage antiplatelet drugs and anticoagulants drugs to balance the risk of bleeding and thrombosis.  (Int Rev Ophthalmol,  2015, 39: 289-296)